Biotechnology Industry | Healthcare Sector | Mr. Yuangang Xie CEO | XSHE Exchange | CNE100000DY9 ISIN |
CN Country | 2,615 Employees | - Last Dividend | 21 Apr 2011 Last Split | 10 Jul 2009 IPO Date |
Established in 1967, Guilin Sanjin Pharmaceutical Co., Ltd. has grown into a leading entity in the research, development, manufacture, and sales of traditional Chinese and natural medicines within China. Distinguished by its flagship products such as Guilin Watermelon Frost and the Sanjin Tablet, the company has carved a niche for itself under the Chinese Traditional Chinese Medicine (TCM) brand. Additionally, its product lineup includes the esteemed Naomaitai capsules among others, showcasing a commitment to blending ancient wisdom with modern healthcare needs. Headquartered in the scenic city of Guilin, China, Guilin Sanjin Pharmaceutical operates under the umbrella of the wider Guilin SanJin Group Co.,Ltd., indicating a robust backing and integrated approach to TCM solutions. This legacy and operational model underscore its mission to promote health and well-being through natural and effective remedies.
Guilin Sanjin Pharmaceutical Co., Ltd. offers an extensive range of products and services, focusing on the cultivation of traditional Chinese and natural medicines. Their notable products include: